| Scholar Rock Holding Corporation | 9.58M | US$527M | 10.7% |
| Kymera Therapeutics, Inc. | 2.94M | US$337M | 6.8% |
| Erasca, Inc. | 11.4M | US$209M | 4.2% |
| Veradermics, Incorporated | 1.66M | US$204M | 4.1% |
| Tango Therapeutics, Inc. | 6.18M | US$193M | 3.9% |
| Revolution Medicines, Inc. | 900K | US$169M | 3.4% |
| Bicara Therapeutics Inc. | 5.6M | US$166M | 3.4% |
| Arrowhead Pharmaceuticals, Inc. | 1.72M | US$140M | 2.8% |
| Beone Medicines Ltd. Class A | 465K | US$133M | 2.7% |
| Edgewise Therapeutics, Inc. | 3.18M | US$129M | 2.6% |
| Rhythm Pharmaceuticals, Inc. | 1.14M | US$126M | 2.6% |
| Lexicon Pharmaceuticals, Inc. | 44.3M | US$106M | 2.2% |
| Enliven Therapeutics, Inc. | 1.77M | US$90.1M | 1.8% |
| Spyre Therapeutics, Inc. | 969K | US$86M | 1.7% |
| Parabilis Medicines, Inc. | 2.99M | US$81.9M | 1.7% |
| Xenon Pharmaceuticals Inc. | 1.32M | US$79.6M | 1.6% |
| Solid Biosciences Inc. | 7.69M | US$76.8M | 1.6% |
| Abivax Sa | 576K | US$76.8M | 1.6% |
| Hemab Therapeutics Holdings, Inc. | 2.09M | US$76.6M | 1.6% |
| Arcus Biosciences, Inc. | 2.42M | US$74.6M | 1.5% |
| Cogent Biosciences, Inc. | 1.86M | US$72M | 1.5% |
| Relay Therapeutics, Inc. | 3.65M | US$68.3M | 1.4% |
| Taysha Gene Therapies, Inc. | 9.85M | US$67.1M | 1.4% |
| Definium Therapeutics, Inc. | 1.42M | US$66.8M | 1.4% |
| Stoke Therapeutics, Inc. | 2M | US$65.3M | 1.3% |
| Disc Medicine, Inc. | 888K | US$65M | 1.3% |
| Cytokinetics, Incorporated | 759K | US$64.7M | 1.3% |
| Septerna, Inc. | 1.9M | US$63.6M | 1.3% |
| Olema Pharmaceuticals, Inc. | 4.86M | US$60.8M | 1.2% |
| Crinetics Pharmaceuticals, Inc. | 1.42M | US$53.2M | 1.1% |
| Kailera Therapeutics, Inc. | 2.21M | US$48.8M | 0.99% |
| Dyne Therapeutics, Inc. | 2.13M | US$47.3M | 0.96% |
| Palvella Therapeutics, Inc. | 257K | US$39.3M | 0.80% |
| Denali Therapeutics Inc. | 1.4M | US$35.9M | 0.73% |
| Remitly Global, Inc. | 1.54M | US$34.6M | 0.70% |
| Cullinan Therapeutics, Inc. | 1.89M | US$34.5M | 0.70% |
| Capital One Financial Corporation | 172K | US$34.4M | 0.70% |
| Trevi Therapeutics, Inc. | 1.79M | US$33.3M | 0.67% |
| Oric Pharmaceuticals, Inc. | 3M | US$32.5M | 0.66% |
| Alphabet Inc (google) Class C | 90,000 | US$32.2M | 0.65% |
| Dbv Technologies Sa | 1.86M | US$30.5M | 0.62% |
| Absci Corporation | 2.47M | US$28.7M | 0.58% |
| Sionna Therapeutics, Inc. | 611K | US$26.9M | 0.54% |
| Rapport Therapeutics, Inc. | 641K | US$26.7M | 0.54% |
| Amylyx Pharmaceuticals, Inc. | 1.48M | US$26.6M | 0.54% |
| Annexon, Inc. | 4.46M | US$25.5M | 0.52% |
| Monopar Therapeutics Inc. | 270K | US$25M | 0.51% |
| Oruka Therapeutics, Inc. | 250K | US$23.8M | 0.48% |
| Seaport Therapeutics, Inc. | 1.1M | US$23.8M | 0.48% |
| Damora Therapeutics, Inc. | 900K | US$23.4M | 0.47% |
| Tyra Biosciences, Inc. | 725K | US$23.2M | 0.47% |
| Zura Bio Limited | 3.73M | US$22M | 0.45% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | 44,700 | US$21.3M | 0.43% |
| Nvidia Corporation | 95,000 | US$19M | 0.38% |
| Rezolute, Inc. | 3.33M | US$17.3M | 0.35% |
| Maplight Therapeutics, Inc. | 450K | US$16.1M | 0.33% |
| Neumora Therapeutics, Inc. | 8.5M | US$14.4M | 0.29% |
| Microsoft Corp. | 37,500 | US$14M | 0.28% |
| Cytomx Therapeutics, Inc. | 3.46M | US$13M | 0.26% |
| Generate Biomedicines, Inc. | 736K | US$12.4M | 0.25% |
| Inhibikase Therapeutics, Inc. | 5.85M | US$11.9M | 0.24% |
| Whitehawk Therapeutics, Inc. | 2.34M | US$10.7M | 0.22% |
| Datadog, Inc. | 40,000 | US$10.4M | 0.21% |
| Servicenow, Inc. | 100K | US$9.93M | 0.20% |
| Broadcom Inc. | 25,000 | US$9.44M | 0.19% |
| Ionq, Inc. | 170K | US$9.05M | 0.18% |
| Amazon.com, Inc. | 32,500 | US$7.75M | 0.16% |
| Crowdstrike Holdings, Inc. | 10,000 | US$7.63M | 0.15% |
| Design Therapeutics, Inc. | 523K | US$7.57M | 0.15% |
| Satellos Bioscience Inc | 892K | US$6.94M | 0.14% |
| Dynatrace, Inc. | 155K | US$6.81M | 0.14% |
| Tenax Therapeutics, Inc. | 427K | US$6.21M | 0.13% |
| Vtv Therapeutics Inc. | 163K | US$6.14M | 0.12% |
| Eloxx Pharmaceuticals, Inc. | 400K | US$5.55M | 0.11% |
| Korro Bio, Inc. | 348K | US$4.58M | 0.09% |
| Invivyd, Inc. | 5M | US$4.36M | 0.09% |
| Ouster, Inc. | 67,500 | US$4.22M | 0.09% |
| Palisade Bio, Inc. | 2M | US$4.18M | 0.08% |
| Aeva Technologies, Inc. | 145K | US$4.18M | 0.08% |
| Seer, Inc. | 2.46M | US$4.08M | 0.08% |
| Gitlab Inc. | 125K | US$3.82M | 0.08% |
| Odyssey Therapeutics, Inc. | 200K | US$3.74M | 0.08% |
| Foghorn Therapeutics Inc. | 721K | US$3.52M | 0.07% |
| Agenus Inc. | 1.06M | US$3.26M | 0.07% |
| Zoetis Inc. | 35,000 | US$2.52M | 0.05% |
| Workiva Inc. | 45,000 | US$2.18M | 0.04% |
| Netflix, Inc. | 25,000 | US$1.78M | 0.04% |
| Kalaris Therapeutics, Inc. | 436K | US$1.77M | 0.04% |
| Quantinuum Inc. | 20,000 | US$1.63M | 0.03% |
| Rani Therapeutics Holdings, Inc. | 2M | US$1.52M | 0.03% |
| Tesla, Inc. | 3,500 | US$1.47M | 0.03% |
| Ke Holdings, Inc. Class A | 100K | US$1.45M | 0.03% |
| Medline Inc. | 25,000 | US$986K | 0.02% |
| Lumentum Holdings Inc. | 1,055 | US$905K | 0.02% |
| Figma Inc | 50,000 | US$905K | 0.02% |
| Gossamer Bio, Inc. | 5.21M | US$857K | 0.02% |
| Fox Corporation | 10,000 | US$522K | 0.01% |
| At&t Inc. | 25,000 | US$518K | 0.01% |
| Nu Holdings Ltd. | 25,000 | US$334K | <0.01% |
| Amer Sports, Inc. | 0 | US$0 | 0.00% |